Search Orphan Drug Designations and Approvals
-
Generic Name: | Coxsackievirus A21 |
---|---|
Date Designated: | 12/15/2005 |
Orphan Designation: | Treatment of stage II (T4), stage III, and stage IV melanoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Viralytics Limited, a wholly owned subsidiary of Merck Sharp & Dohme, LLC P. O. Box 1045 Unit 8/33 Ryde Road, Pymble, , NSW Australia The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-